Clinical trial
Lycopene in Treating Patients With Metastatic Prostate Cancer
NCT00068731 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00068731 |
|---|---|
| Title | Lycopene in Treating Patients With Metastatic Prostate Cancer |
| Official title | A Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA Elevation |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement |
| Interventions | lycopene |
| Enrollment | 47 |
| Start date | Jan 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Oct 1, 2009 |
| First posted | Sep 11, 2003 |
| Last update posted | Jul 13, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: